Showing 36,902 results

Pregnancy and vertical transmission

Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART

News
7 March 2011
HIV & criminal law

Partners study expands our knowledge of HIV transmission risk

News
3 March 2011
PrEP policies & guidelines

Modellers examine the cost-effectiveness of PrEP in Africa

News
3 March 2011
PrEP policies & guidelines

Forecasters agree PrEP/microbicides could cut HIV infections in South Africa

News
3 March 2011
New & experimental HIV treatments

Once-daily raltegravir found inferior to twice-daily dosing

News
3 March 2011
Resistance

Is HIV drug resistance spreading? Early warning signals say 'yes'

News
3 March 2011
New & experimental hepatitis C treatment

Telaprevir works well for people with HIV/HCV co-infection

News
2 March 2011
PrEP science

First pills-versus-gel trial finds US women prefer oral PrEP

News
2 March 2011
Bone & joint problems

Does immune reconstitution contribute to ART-related bone loss?

News
2 March 2011
PrEP science

New data from PrEP study shed light on adherence, bone mineral loss and resistance

News
2 March 2011
Side effects

Abacavir not linked to increased risk of heart attack, reports US FDA

News
2 March 2011
Ageing & HIV

Decreased limb muscle and increased abdominal fat linked to higher mortality in people with HIV

News
2 March 2011
Viral load

Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa

News
1 March 2011
New & experimental HIV treatments

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

News
1 March 2011
New & experimental HIV treatments

Zinc finger gene therapy produces HIV-resistant CD4 T-cells

News
1 March 2011
Vaginal rings & topical PrEP

Vaginal microbicides may not be safe for rectal use: gels being reformulated

News
1 March 2011
Vaginal rings & topical PrEP

One dose of raltegravir gel three hours after sex might prevent HIV infection

News
1 March 2011
TB treatment

Antiretroviral treatment in TB patients: patients with CD4 counts below 50 need to start ART quickly

News
28 February 2011
PrEP science

Truvada PrEP remains effective against HIV with 3TC/FTC resistance in animal study

News
28 February 2011
Self-testing & home testing

Self-testing for HIV proves highly acceptable in Malawi

News
28 February 2011
Circumcision

Five years on from circumcision trial, nine in ten participants are circumcised and HIV incidence is two-thirds lower

News
28 February 2011
Condoms & lubricant

Study finds most lubricants damage rectal cells and some increase HIV activity

News
26 February 2011
Cardiovascular disease

Low HDL cholesterol the biggest modifiable risk for cardiovascular disease in patients with HIV (updated)

News
25 February 2011
Child developmental issues

Anaemia more likely in infants exposed to maternal ARVs during pregnancy and breastfeeding

News
25 February 2011